- Report
- May 2024
- 130 Pages
Global
From €5428EUR$5,950USD£4,668GBP
- Report
- April 2025
- 459 Pages
Global
From €5109EUR$5,600USD£4,394GBP
- Report
- April 2025
- 92 Pages
Global
From €5109EUR$5,600USD£4,394GBP
- Report
- January 2025
- 143 Pages
Global
From €2736EUR$2,999USD£2,353GBP
- Report
- September 2024
- 141 Pages
Global
From €2736EUR$2,999USD£2,353GBP
- Report
- September 2024
- 142 Pages
Global
From €2736EUR$2,999USD£2,353GBP
- Report
- July 2024
- 135 Pages
Global
From €2736EUR$2,999USD£2,353GBP
- Report
- February 2025
- 120 Pages
Global
From €2272EUR$2,490USD£1,954GBP
- Report
- February 2025
- 120 Pages
Global
From €2272EUR$2,490USD£1,954GBP
- Report
- January 2025
- 170 Pages
Global
From €2272EUR$2,490USD£1,954GBP
- Report
- November 2024
- 100 Pages
Global
From €2272EUR$2,490USD£1,954GBP
- Report
- April 2025
- 278 Pages
Global
From €5109EUR$5,600USD£4,394GBP
- Report
- April 2025
- 386 Pages
Global
From €5109EUR$5,600USD£4,394GBP
- Report
- April 2025
- 273 Pages
Global
From €5109EUR$5,600USD£4,394GBP
- Report
- April 2025
- 270 Pages
Global
From €5109EUR$5,600USD£4,394GBP
- Report
- April 2025
- 379 Pages
Global
From €5109EUR$5,600USD£4,394GBP
- Report
- April 2025
- 149 Pages
Global
From €5109EUR$5,600USD£4,394GBP
- Report
- April 2025
- 93 Pages
Global
From €5109EUR$5,600USD£4,394GBP
- Report
- April 2025
- 93 Pages
Global
From €5109EUR$5,600USD£4,394GBP
- Report
- April 2025
- 93 Pages
Global
From €5109EUR$5,600USD£4,394GBP

Glaucoma is a group of eye diseases that damage the optic nerve, leading to vision loss. It is the leading cause of irreversible blindness worldwide. The glaucoma market within the optical industry is focused on providing treatments and technologies to diagnose and manage the disease. This includes medications, laser treatments, and surgical procedures. Additionally, the market includes devices such as tonometers, optical coherence tomography (OCT) systems, and visual field analyzers. These devices are used to measure intraocular pressure, detect structural changes in the eye, and assess the extent of vision loss.
Companies in the glaucoma market include Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Glaukos, Hoya, Nidek, Topcon, and Ziemer Ophthalmic Systems. Show Less Read more